Intelliheart tests in Amcal pharmacies

By Dylan Bushell-Embling
Friday, 13 June, 2008

IM Medical (ASX: IMI) has reached an exclusive agreement with Sigma Pharmaceuticals that will see the Intelliheart cardiac risk assessment tests sold through Sigma's Amcal network.

The Amcal network includes over 700 Amcal, Amcal Max and Guardian pharmacies throughout the country.

The product will initially be rolled out to over 200 pharmacies throughout Victoria in July. Stores in other states will begin stocking the product in the next few months.

Under the agreement Sigma has the right to produce and market other products using the Intelliheart brand name.

Intelliheart is the only widely available diagnostic which tests for both heart rate variability and arterial stiffness.

Related News

SEQ koala population carries immunity to retrovirus

Koalas from a population north of the Brisbane River appear to have evolved a unique genomic...

RSV immunisation program for babies slashes hospital stays

An Australian-first study has demonstrated the effectiveness of immunisation against respiratory...

A targeted treatment option for psoriasis

New research from MedUni Vienna paves the way for the development of a therapy that not only...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd